1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. News
  7. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  05/27 04:51:20 pm EDT
6.150 CAD   -13.62%
05/27Canopy Growth reports Q4 net revenue down 25 per cent from year ago
AQ
05/27More Detail From Piper Sandler' Lavery on Canopy Growth
MT
05/27PIPER SANDLER ON CANOPY GROWTH : "Profitability Still Years Away"
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

01/19/2022 | 07:11am EDT

Martha Stewart CBD unveiled Martha Stewart CBD Wellness Topicals, marking the brand's first-ever category expansion in its growing CBD portfolio. Martha Stewart CBD provides consumers with an easy way to manage their needs throughout the day with convenient and trusted CBD products – including gummies, oils, softgels and the new CBD Wellness Topicals. Martha Stewart CBD Wellness Topicals offer simple solutions that are easy to use, easy to love, and are a part of Martha's wellness portfolio. Developed to improve daily wellbeing in specific ways, the topicals line consists of Super Strength CBD Cream designed for muscle recovery, Sleep Science CBD Cream designed for better sleep and Daily De-Stress CBD Cream designed for stress management. Each product is formulated with market leading levels of CBD, powerful co-actives and proven-to-work aroma-technology formulated specifically for each need, all carefully balanced for optimal results. The effective formulas were created by Martha in partnership with Marquee Brands and Canopy Growth Corporation, a diversified cannabis and cannabinoid-based consumer product company. Leveraging Canopy Growth's unparalleled consumer insights and continued innovation in the space, the new line uses cutting edge aroma-technology proven to activate key areas of the brain to induce mood state change around the areas of relaxation, reduced anxiety, emotion and memory. Martha Stewart CBD Wellness Topicals are formulated with US-derived broad-spectrum CBD, with the line featuring market leading levels of CBD with the lowest price per mg of CBD versus competitors. At launch, each SKU will be available for purchase in 20mL, 50mL and 150mL sizes. Martha Stewart CBD Wellness Topicals: Super Strength CBD Cream for muscle recovery, featuring powerful co-actives, including magnesium and ginger: 150 mL (7,500 mg CBD) - $99.99; 50 mL (2,500 mg CBD) - $44.99; and 20 mL (1,000 mg CBD) - $24.99. Sleep Science CBD Cream for better sleep, featuring aroma-technology essential oils, including lavender & vetiver: 150 mL (3,000 mg CBD) - $89.99; 50 mL (1000 mg CBD) - $39.99; and 20 mL (400 mg CBD) - $19.99. Daily De-Stress CBD Cream for stress management, featuring aroma-technology essential oils, including neroli & ho wood: 150 mL (4500 mg CBD) - $79.99; 50 mL (1,500 mg CBD) - $34.99; and 20 mL (600 mg CBD) - $19.99.


© S&P Capital IQ 2022
All news about CANOPY GROWTH CORPORATION
05/27Canopy Growth reports Q4 net revenue down 25 per cent from year ago
AQ
05/27More Detail From Piper Sandler' Lavery on Canopy Growth
MT
05/27PIPER SANDLER ON CANOPY GROWTH : "Profitability Still Years Away"
MT
05/27Canopy Growth Down 16% to Near 6-Year Low as Reports Q4 Results
MT
05/27Canopy Growth Aims to Turn Profit in Fiscal 2024 After Quarterly Results Miss Views on ..
MT
05/27Toronto index up as tech, cyclical stocks gain
RE
05/27TRANSCRIPT : Canopy Growth Corporation, Q4 2022 Earnings Call, May 27, 2022
CI
05/27CANOPY GROWTH : Reports Fourth Quarter and Fiscal year 2022 Financial Results - Form 8-K
PU
05/27Canopy Growth Down 11% in US Pre-Market as Reports Q4 Net Revenue Fell 25% YoY
MT
05/27Stocks Set for Weekly Gains as as US Futures Rise; Europe, Asia Stronger
MT
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Financials
Sales 2022 544 M 427 M 427 M
Net income 2022 100 M 78,6 M 78,6 M
Net Debt 2022 38,1 M 29,9 M 29,9 M
P/E ratio 2022 19,8x
Yield 2022 -
Capitalization 2 478 M 1 944 M 1 944 M
EV / Sales 2022 4,62x
EV / Sales 2023 5,00x
Nbr of Employees 3 259
Free-Float 62,4%
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 21
Last Close Price 6,15 CAD
Average target price 9,05 CAD
Spread / Average Target 47,2%
EPS Revisions
Managers and Directors
David Eric Klein Chief Executive Officer & Non-Independent Director
Judy Hong Chief Financial Officer & VP-Investor Relations
Judy A. Schmeling Chairman
Ru Wadasinghe Chief Information Officer
Mark A. Ware Chief Medical Officer